Search research articles
Contact Us
Filters
Showing results (101-110 of 186) with videos related to
Page
of 19
Sort By:
Kidney International Reports
|
January 16, 2026
Characterizing the NIH Activity and Chronicity Indices in 2 Independent Lupus Nephritis Cohorts
Valentina Querin, Natasha Jordan, David P D'Cruz, et al.
Revista Clinica Espanola
|
April 26, 2024
Comparing pregnancy outcomes in patients with Systemic Lupus Erythematosus (SLE) and Undifferentiated Connective Tissue Disease (UCTD): a descriptive cohort study
Candido Muñoz Muñoz, Filipa Farinha, Thomas McDonnell, et al.
Lupus Science & Medicine
|
November 15, 2014
Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulin
Jessica J Manson, Kevin Mills, Elizabeth Jury, et al.
Molecular Immunology
|
September 9, 2011
Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies
Charis Pericleous, Jennifer Miles, Diego Esposito, et al.
Rheumatology (Oxford, England)
|
November 26, 2009
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
David Isenberg, Gerald B Appel, Gabriel Contreras, et al.
Arthritis Care & Research
|
May 17, 2012
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)
Lisa G Rider, Victoria P Werth, Adam M Huber, et al.
Kidney International Reports
|
May 2, 2022
Use of Glomerular CD68+ Cells as a Surrogate Marker for Endocapillary Hypercellularity in Lupus Nephritis
Elisabeth M J Bos, Shirish R Sangle, Suzanne Wilhelmus, et al.
Rheumatology (Oxford, England)
|
February 11, 2010
Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis
Tamar Rubinstein, Milena Pitashny, Benjamin Levine, et al.
The New England Journal of Medicine
|
November 18, 2011
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis
Mary Anne Dooley, David Jayne, Ellen M Ginzler, et al.
Scientific Reports
|
September 9, 2017
Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome
Bahar Artim-Esen, Natalia Smoktunowicz, Thomas McDonnell, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 186) with videos related to
Sort By:
Page
of 19
Kidney International Reports
|
January 16, 2026
Characterizing the NIH Activity and Chronicity Indices in 2 Independent Lupus Nephritis Cohorts
Valentina Querin, Natasha Jordan, David P D'Cruz, et al.
Revista Clinica Espanola
|
April 26, 2024
Comparing pregnancy outcomes in patients with Systemic Lupus Erythematosus (SLE) and Undifferentiated Connective Tissue Disease (UCTD): a descriptive cohort study
Candido Muñoz Muñoz, Filipa Farinha, Thomas McDonnell, et al.
Lupus Science & Medicine
|
November 15, 2014
Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulin
Jessica J Manson, Kevin Mills, Elizabeth Jury, et al.
Molecular Immunology
|
September 9, 2011
Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies
Charis Pericleous, Jennifer Miles, Diego Esposito, et al.
Rheumatology (Oxford, England)
|
November 26, 2009
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
David Isenberg, Gerald B Appel, Gabriel Contreras, et al.
Arthritis Care & Research
|
May 17, 2012
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)
Lisa G Rider, Victoria P Werth, Adam M Huber, et al.
Kidney International Reports
|
May 2, 2022
Use of Glomerular CD68+ Cells as a Surrogate Marker for Endocapillary Hypercellularity in Lupus Nephritis
Elisabeth M J Bos, Shirish R Sangle, Suzanne Wilhelmus, et al.
Rheumatology (Oxford, England)
|
February 11, 2010
Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis
Tamar Rubinstein, Milena Pitashny, Benjamin Levine, et al.
The New England Journal of Medicine
|
November 18, 2011
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis
Mary Anne Dooley, David Jayne, Ellen M Ginzler, et al.
Scientific Reports
|
September 9, 2017
Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome
Bahar Artim-Esen, Natalia Smoktunowicz, Thomas McDonnell, et al.
Page
of 19